Results 111 to 120 of about 78,660 (285)

Successful Treatment of Rubral Tremor by High-Dose Trihexyphenidyl: A Case Report

open access: yesKaohsiung Journal of Medical Sciences, 2006
A 24-year-old male suffered from acute-onset right-sided hemiparesis, dysarthria, and ophthalmoplegia in February 2001. Brain magnetic resonance imaging revealed a cavernous angioma with hemorrhage over the left thalamus. Moreover, some rhythmic, coarse,
Li-Min Liou, Pang-Ying Shih
doaj   +1 more source

Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Levothyroxine (LT4) is the standard treatment for hypothyroidism and the most widely prescribed medication worldwide. Although generally safe, regulatory reports list potential cardiac, neuropsychiatric and musculoskeletal adverse events (AEs). Clarifying their clinical relevance is essential.
Bala Swetha Baskaran   +2 more
wiley   +1 more source

Holmes Tremor Following Thalamic Tuberculoma—A Case Report and Literature Review

open access: yesClinical Case Reports
Tremor is the most common movement disorder, defined as a rhythmical oscillatory involuntary movement that can affect almost any body part. Holmes Tremor (HT) is an irregular, slow‐frequency (
Abera Kuma   +6 more
doaj   +1 more source

Unsupervised Parkinson’s Disease Assessment [PDF]

open access: yes, 2018
Parkinson’s Disease (PD) is a progressive neurological disease that affects 6.2 million people worldwide. The most popular clinical method to measure PD tremor severity is a standardized test called the Unified Parkinson’s Disease Rating Scale (UPDRS ...
Adranly, Alexander S.   +2 more
core   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher   +7 more
wiley   +1 more source

Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson's Disease. [PDF]

open access: yesTremor Other Hyperkinet Mov (N Y), 2023
Brillman S   +8 more
europepmc   +1 more source

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop   +3 more
wiley   +1 more source

Acute effects of a single session of multitarget continuous Theta-Burst stimulation for essential Tremor: A Randomized, Sham-Controlled trial

open access: yesNeuroImage: Clinical
Background: Current treatments for essential tremor (ET) are suboptimal. This study aims to assess the safety and acute effects of a single session, multitarget continuous theta-burst stimulation (cTBS) applied to the bilateral primary motor cortex (M1 ...
Anling Luo   +5 more
doaj   +1 more source

A Wearable Vibratory Device (The Emma Watch) to Address Action Tremor in Parkinson Disease: Pilot Feasibility Study. [PDF]

open access: yesJMIR Biomed Eng, 2023
Pacheco A   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy